# DuPont de Nemours, Inc.: financial statements, quarterly

DD · NYSE · CIK 1666700 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dd.md) · [Financials](/companies/dd/financials.md) · [Filings](/companies/dd/filings.md) · [Insiders](/companies/dd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,058](/filings/0001666700-24-000036.md) | [(2,556) d](/filings/0001666700-26-000013.md) | [1,599](/filings/0001666700-26-000013.md) | [1,717](/filings/0001666700-26-000013.md) | [1,714](/filings/0001666700-26-000013.md) | [1,689](/filings/0001666700-26-000013.md) | [1,612](/filings/0001666700-26-000031.md) | [1,749](/filings/0001666700-26-000053.md) | [1,795](/filings/0001666700-26-000013.md) | [1,693](/filings/0001666700-26-000013.md) | [1,681](/filings/0001666700-26-000031.md) | [1,819](/filings/0001666700-26-000053.md) |
| Cost of revenue | $m | [1,954](/filings/0001666700-24-000036.md) | [(1,525) d](/filings/0001666700-26-000013.md) | [1,098](/filings/0001666700-26-000013.md) | [1,131](/filings/0001666700-26-000013.md) | [1,134](/filings/0001666700-26-000013.md) | [1,136](/filings/0001666700-26-000013.md) | [1,069](/filings/0001666700-26-000031.md) | [1,143](/filings/0001666700-26-000053.md) | [1,179](/filings/0001666700-26-000013.md) | [1,095](/filings/0001666700-26-000013.md) | [1,079](/filings/0001666700-26-000031.md) | [1,180](/filings/0001666700-26-000053.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [128](/filings/0001666700-24-000036.md) | [(188) d](/filings/0001666700-26-000013.md) | [125](/filings/0001666700-25-000020.md) | [134](/filings/0001666700-25-000043.md) | [127](/filings/0001666700-25-000061.md) | [(167) d](/filings/0001666700-26-000013.md) | [50.0](/filings/0001666700-26-000031.md) | [53.0](/filings/0001666700-26-000053.md) | [140](/filings/0001666700-25-000061.md) | [(211) d](/filings/0001666700-26-000013.md) | [47.0](/filings/0001666700-26-000031.md) | [42.0](/filings/0001666700-26-000053.md) |
| Selling, general and administrative | $m | [360](/filings/0001666700-24-000036.md) | [(167) d](/filings/0001666700-26-000013.md) | [384](/filings/0001666700-25-000020.md) | [418](/filings/0001666700-25-000043.md) | [368](/filings/0001666700-25-000061.md) | [(158) d](/filings/0001666700-26-000013.md) | [234](/filings/0001666700-26-000031.md) | [262](/filings/0001666700-26-000053.md) | [387](/filings/0001666700-25-000061.md) | [(108) d](/filings/0001666700-26-000013.md) | [255](/filings/0001666700-26-000031.md) | [269](/filings/0001666700-26-000053.md) |
| Income tax | $m | [117](/filings/0001666700-24-000036.md) | [(504) d](/filings/0001666700-26-000013.md) | [84.0](/filings/0001666700-25-000020.md) | [120](/filings/0001666700-25-000043.md) | [99.0](/filings/0001666700-25-000061.md) | [(75.0) d](/filings/0001666700-26-000013.md) | [17.0](/filings/0001666700-26-000031.md) | [54.0](/filings/0001666700-26-000053.md) | [19.0](/filings/0001666700-25-000061.md) | [(89.0) d](/filings/0001666700-26-000013.md) | [31.0](/filings/0001666700-26-000031.md) | [75.0](/filings/0001666700-26-000053.md) |
| Net income | $m | [319](/filings/0001666700-24-000036.md) | [(22.0) d](/filings/0001666700-26-000013.md) | [188](/filings/0001666700-26-000013.md) | [178](/filings/0001666700-26-000013.md) | [454](/filings/0001666700-26-000013.md) | [(117)](/filings/0001666700-26-000013.md) | [(589)](/filings/0001666700-26-000031.md) | [59.0](/filings/0001666700-26-000053.md) | [(123)](/filings/0001666700-26-000013.md) | [(126)](/filings/0001666700-26-000013.md) | [161](/filings/0001666700-26-000031.md) | [143](/filings/0001666700-26-000053.md) |
| Diluted EPS | $ per share | [0.70](/filings/0001666700-24-000036.md) | not reported | [0.44](/filings/0001666700-26-000013.md) | [0.43](/filings/0001666700-26-000013.md) | [1.08](/filings/0001666700-26-000013.md) | [(0.28)](/filings/0001666700-26-000013.md) | [(1.40)](/filings/0001666700-26-000031.md) | [0.42](/filings/0001666700-26-000053.md) | [(0.29)](/filings/0001666700-26-000013.md) | [(0.30)](/filings/0001666700-26-000013.md) | [0.39](/filings/0001666700-26-000031.md) | [1.05](/filings/0001666700-26-000053.md) |
| Basic EPS | $ per share | [0.71](/filings/0001666700-24-000036.md) | not reported | [0.44](/filings/0001666700-26-000013.md) | [0.43](/filings/0001666700-26-000013.md) | [1.09](/filings/0001666700-26-000013.md) | [(0.28)](/filings/0001666700-26-000013.md) | [(1.41)](/filings/0001666700-26-000031.md) | [0.42](/filings/0001666700-26-000053.md) | [(0.29)](/filings/0001666700-26-000013.md) | [(0.30)](/filings/0001666700-26-000013.md) | [0.39](/filings/0001666700-26-000031.md) | [1.05](/filings/0001666700-26-000053.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.3](/filings/0001666700-23-000087.md) | [2.4](/filings/0001666700-25-000005.md) | [1.9](/filings/0001666700-24-000013.md) | [1.5](/filings/0001666700-24-000031.md) | [1.6](/filings/0001666700-24-000036.md) | [1.8](/filings/0001666700-26-000013.md) | [1.8](/filings/0001666700-25-000020.md) | [1.8](/filings/0001666700-25-000043.md) | [2.0](/filings/0001666700-25-000061.md) | [0.7](/filings/0001666700-26-000053.md) | [0.7](/filings/0001666700-26-000031.md) | [1.7](/filings/0001666700-26-000053.md) |
| Current assets | $bn | [7.9](/filings/0001666700-23-000087.md) | [7.5](/filings/0001666700-25-000005.md) | [7.1](/filings/0001666700-24-000013.md) | [6.2](/filings/0001666700-24-000031.md) | [6.4](/filings/0001666700-24-000036.md) | [20.8](/filings/0001666700-26-000013.md) | [6.5](/filings/0001666700-25-000020.md) | [6.9](/filings/0001666700-25-000043.md) | [10.0](/filings/0001666700-25-000061.md) | [5.6](/filings/0001666700-26-000053.md) | [5.6](/filings/0001666700-26-000031.md) | [4.9](/filings/0001666700-26-000053.md) |
| Total assets | $bn | [39.1](/filings/0001666700-23-000087.md) | [38.6](/filings/0001666700-26-000013.md) | [37.7](/filings/0001666700-24-000013.md) | [36.6](/filings/0001666700-24-000031.md) | [37.5](/filings/0001666700-24-000036.md) | [36.6](/filings/0001666700-26-000013.md) | [36.0](/filings/0001666700-25-000020.md) | [36.6](/filings/0001666700-25-000043.md) | [38.0](/filings/0001666700-25-000061.md) | [21.6](/filings/0001666700-26-000053.md) | [21.4](/filings/0001666700-26-000031.md) | [21.1](/filings/0001666700-26-000053.md) |
| Current liabilities | $bn | [3.7](/filings/0001666700-23-000087.md) | [3.1](/filings/0001666700-25-000005.md) | [3.0](/filings/0001666700-24-000013.md) | [2.8](/filings/0001666700-24-000031.md) | [2.8](/filings/0001666700-24-000036.md) | [5.5](/filings/0001666700-26-000013.md) | [4.6](/filings/0001666700-25-000020.md) | [4.9](/filings/0001666700-25-000043.md) | [5.0](/filings/0001666700-25-000061.md) | [2.3](/filings/0001666700-26-000053.md) | [2.1](/filings/0001666700-26-000031.md) | [2.0](/filings/0001666700-26-000053.md) |
| Total liabilities | $bn | [14.5](/filings/0001666700-23-000087.md) | [13.8](/filings/0001666700-25-000005.md) | [13.7](/filings/0001666700-24-000013.md) | [12.8](/filings/0001666700-24-000031.md) | [12.8](/filings/0001666700-24-000036.md) | [12.8](/filings/0001666700-26-000013.md) | [12.7](/filings/0001666700-25-000020.md) | [13.0](/filings/0001666700-25-000043.md) | [14.7](/filings/0001666700-25-000061.md) | [7.5](/filings/0001666700-26-000053.md) | [7.2](/filings/0001666700-26-000031.md) | [7.2](/filings/0001666700-26-000053.md) |
| Long-term debt | $bn | [8.2](/filings/0001666700-23-000087.md) | [7.9](/filings/0001666700-24-000036.md) | [7.9](/filings/0001666700-24-000013.md) | [7.2](/filings/0001666700-24-000031.md) | [7.2](/filings/0001666700-24-000036.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.5](/filings/0001666700-23-000087.md) | [0.0](/filings/0001666700-25-000005.md) | not reported | not reported | not reported | [1.8](/filings/0001666700-26-000013.md) | [1.8](/filings/0001666700-25-000020.md) | [1.8](/filings/0001666700-25-000043.md) | [1.9](/filings/0001666700-25-000061.md) | [0.0](/filings/0001666700-26-000053.md) | [0.0](/filings/0001666700-26-000031.md) | [0.0](/filings/0001666700-26-000053.md) |
| Short-term borrowings | $bn | not reported | [0.0](/filings/0001666700-26-000013.md) | not reported | not reported | not reported | [0.0](/filings/0001666700-26-000013.md) | not reported | not reported | not reported | [0.1](/filings/0001666700-26-000053.md) | [0.0](/filings/0001666700-26-000031.md) | [0.0](/filings/0001666700-26-000053.md) |
| Shareholders' equity | $bn | [24.2](/filings/0001666700-23-000087.md) | [24.3](/filings/0001666700-25-000005.md) | [23.6](/filings/0001666700-24-000013.md) | [23.3](/filings/0001666700-24-000031.md) | [24.2](/filings/0001666700-24-000036.md) | [23.4](/filings/0001666700-26-000013.md) | [22.8](/filings/0001666700-25-000020.md) | [23.1](/filings/0001666700-25-000043.md) | [22.9](/filings/0001666700-25-000061.md) | [13.9](/filings/0001666700-26-000053.md) | [14.0](/filings/0001666700-26-000031.md) | [13.8](/filings/0001666700-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [740 d](/filings/0001666700-24-000036.md) | [(700) d](/filings/0001666700-26-000013.md) | [493](/filings/0001666700-25-000020.md) | [527 d](/filings/0001666700-25-000043.md) | [497 d](/filings/0001666700-25-000061.md) | [(752) d](/filings/0001666700-26-000013.md) | [77.0](/filings/0001666700-26-000031.md) | [74.0 d](/filings/0001666700-26-000053.md) | [1,109 d](/filings/0001666700-25-000061.md) | [(700) d](/filings/0001666700-26-000013.md) | [232](/filings/0001666700-26-000031.md) | [400 d](/filings/0001666700-26-000053.md) |
| Capital expenditure | $m | [119 d](/filings/0001666700-24-000036.md) | [(172) d](/filings/0001666700-26-000013.md) | [207](/filings/0001666700-25-000020.md) | [102 d](/filings/0001666700-25-000043.md) | [67.0 d](/filings/0001666700-25-000061.md) | [(91.0) d](/filings/0001666700-26-000013.md) | [122](/filings/0001666700-26-000031.md) | [50.0 d](/filings/0001666700-26-000053.md) | [311 d](/filings/0001666700-25-000061.md) | [(150) d](/filings/0001666700-26-000013.md) | [102](/filings/0001666700-26-000031.md) | [76.0 d](/filings/0001666700-26-000053.md) |
| Dividends paid | $m | [165 d](/filings/0001666700-24-000036.md) | [156 d](/filings/0001666700-26-000013.md) | [159](/filings/0001666700-25-000020.md) | [158 d](/filings/0001666700-25-000043.md) | [159 d](/filings/0001666700-25-000061.md) | [159 d](/filings/0001666700-26-000013.md) | [172](/filings/0001666700-26-000031.md) | [171 d](/filings/0001666700-26-000053.md) | [172 d](/filings/0001666700-25-000061.md) | [82.0 d](/filings/0001666700-26-000013.md) | [82.0](/filings/0001666700-26-000031.md) | [81.0 d](/filings/0001666700-26-000053.md) |
| Share repurchases | $m | [2,000 d](/filings/0001666700-23-000087.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [500](/filings/0001666700-23-000087.md) | [460](/filings/0001666700-24-000013.md) | [460](/filings/0001666700-24-000031.md) | [453](/filings/0001666700-24-000036.md) | [424](/filings/0001666700-25-000020.md) | [419](/filings/0001666700-25-000043.md) | [420](/filings/0001666700-25-000061.md) | [420](/filings/0001666700-26-000031.md) | [140](/filings/0001666700-26-000053.md) | [420](/filings/0001666700-25-000061.md) | [413](/filings/0001666700-26-000031.md) | [137](/filings/0001666700-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 135,042,975 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001666700-26-000053.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.